Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure

Journal of the American College of Cardiology

Volumn 69, Issue 10, 2017, Pages 1275-1285

  Mantel, Ängla ^a   Holmqvist, Marie ^a   Andersson, Daniel C ^a,b   Lund, Lars H ^a,b   Askling, Johan ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cohort; epidemiology; risk factors; Sweden

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; RHEUMATOID ARTHRITIS; SWEDISH CITIZEN; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SWEDEN; TIME FACTOR;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POPULATION SURVEILLANCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 85014467857     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.12.033     Document Type: Article

References (38)

1. 1 Avina-Zubieta, J.A., Thomas, J., Sadatsafavi, M., Lehman, A.J., Lacaille, D., Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71 (2012), 1524–1529.
2. 2 Nicola, P.J., Maradit-Kremers, H., Roger, V.L., et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52 (2005), 412–420.
3. 3 Gabriel, S.E., Crowson, C.S., O'Fallon, W.M., Comorbidity in arthritis. J Rheumatol 26 (1999), 2475–2479.
4. 4 Wolfe, F., Freundlich, B., Straus, W.L., Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30 (2003), 36–40.
5. 5 Nicola, P.J., Crowson, C.S., Maradit-Kremers, H., et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54 (2006), 60–67.
6. 6 Myasoedova, E., Crowson, C.S., Nicola, P.J., et al. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 38 (2011), 1601–1606.
7. 7 Schau, T., Gottwald, M., Butter, C., Zaenker, M., Prevalence of heart failure in rheumatoid arthritis is doubled in remission yet quadrupled in active disease [abstract FRII0099]. Ann Rheum Dis, 73, 2014, 417.
8. 8 Crowson, C.S., Nicola, P.J., Kremers, H.M., et al. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?. Arthritis Rheum 52 (2005), 3039–3044.
9. 9 Hansson, G.K., Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005), 1685–1695.
10. 10 Krum, H., Abraham, W.T., Heart failure. Lancet 373 (2009), 941–955.
11. 11 Ludvigsson, J.F., Otterblad-Olausson, P., Pettersson, B.U., Ekbom, A., The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24 (2009), 659–667.
12. 12 Waldenlind, K., Eriksson, J.K., Grewin, B., Askling, J., Validation of the rheumatoid arthritis diagnosis in the Swedish National patient register: a cohort study from Stockholm County. BMC Musculoskelet Disord, 15, 2014, 432.
13. 13 Ingelsson, E., Arnlov, J., Sundstrom, J., Lind, L., The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7 (2005), 787–791.
14. 14 Libby, P., Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32 (2012), 2045–2051.
15. 15 Kaptoge, S., Di Angelantonio, E., Pennells, L., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 367 (2012), 1310–1320.
16. 16 Mantel, A., Holmqvist, M., Nyberg, F., et al. Risk factors for the rapid risk increase of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study. Arthritis Rheumatol 67 (2015), 2845–2854.
17. 17 Gonzalez-Gay, M.A., Gonzalez-Juanatey, C., Lopez-Diaz, M.J., et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Care Res 57 (2007), 25–132.
18. 18 Ajeganova, S., Andersson, M.L., Frostegard, J., Hafstrom, I., Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol 40 (2013), 1958–1966.
19. 19 Goodson, N.J., Symmons, D.P., Scott, D.G., Bunn, D., Lunt, M., Silman, A.J., Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 52 (2005), 2293–2299.
20. 20 Holmqvist, M.E., Wedren, S., Jacobsson, L.T., et al. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 268 (2010), 578–585.
21. 21 Holmqvist, M.E., Wedren, S., Jacobsson, L.T.H., et al. No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. Arthritis Rheum 60 (2009), 2861–2869.
22. 22 Krishnagopalan, S., Kumar, A., Parrillo, J.E., Kumar, A., Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 8 (2002), 376–388.
23. 23 Marchant, D.J., Boyd, J.H., Lin, D.C., Granville, D.J., Garmaroudi, F.S., McManus, B.M., Inflammation in myocardial diseases. Circ Res 110 (2012), 126–144.
24. 24 Lim, S.L., Lam, C.S., Segers, V.F., Brutsaert, D.L., De Keulenaer, G.W., Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction. Eur Heart J 36 (2015), 2050–2060.
25. 25 Dibbs, Z.I., Diwan, A., Nemoto, S., et al. Targeted overexpression of transmembrane tumor necrosis factor provokes a concentric cardiac hypertrophic phenotype. Circulation 108 (2003), 1002–1008.
26. 26 Solomon, D.H., Rassen, J.A., Kuriya, B., et al. Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist. Ann Rheum Dis 72 (2013), 1813–1818.
27. 27 Kotyla, P.J., Owczarek, A., Rakoczy, J., Lewicki, M., Kucharz, E.J., Emery, P., Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide. J Rheumatol 39 (2012), 701–706.
28. 28 Heslinga, S.C., Van Sijl, A.M., De Boer, K., Van Halm, V.P., Nurmohamed, M.T., Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review. Curr Med Chem 22 (2015), 1892–1902.
29. 29 Stolt, P., Bengtsson, C., Nordmark, B., et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 62 (2003), 835–841.
30. 30 Giles, J.T., Fert-Bober, J., Park, J.K., et al. Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res Ther, 14, 2012, R39.
31. 31 Fert-Bober, J., Giles, J.T., Holewinski, R.J., et al. Citrullination of myofilament proteins in heart failure. Cardiovasc Res 108 (2015), 232–242.
32. 32 Zannad, F., Briancon, S., Juilliere, Y., et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study: Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine [published correction appears in J Am Coll Cardiol 1999;34:1363]. J Am Coll Cardiol 33 (1999), 734–742.
33. 33 Bjorkbacka, H., Lavant, E.H., Fredrikson, G.N., et al. Weak associations between human leucocyte antigen genotype and acute myocardial infarction. J Intern Med 268 (2010), 50–58.
34. 34 Linnersjö, A., Hammar, N., Gustavsson, A., Reuterwall, C., Recent time trends in acute myocardial infarction in Stockholm, Sweden. Int J Cardiol 76 (2000), 17–21.
35. 35 Maradit-Kremers, H., Crowson, C.S., Nicola, P.J., et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52 (2005), 402–411.
36. 36 del Rincón, I., O'Leary, D.H., Freeman, G.L., Escalante, A., Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 195 (2007), 354–360.
37. 37 Karpouzas, G.A., Malpeso, J., Choi, T.Y., Li, D., Munoz, S., Budoff, M.J., Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis 73 (2014), 1797–1804.
38. 38 Ludvigsson, J.F., Andersson, E., Ekbom, A., et al. External review and validation of the Swedish national inpatient register. BMC Public Health, 11, 2011, 450.